GrayMatters Health
Agent46Agent Readiness: 46/100. Above median. Measured by StartupHub.ai. Median 41.Health tech company developing digital biomarkers for mental disorder treatment.
About
GrayMatters Health (GMH) is a health technology company focused on developing and marketing innovative solutions for treating mental disorders. Their approach is based on the world's first digital brain biomarkers, aiming to provide more precise and effective therapeutic interventions. The company has received recognition, including the 2023 USA Prix Galien Best Startup award, and is actively deploying its FDA-cleared Prism for PTSD.
Key facts
At-a-glance profile data
- Website
- graymatters-health.com
- Headquarters
- New York, United States
- Founded
- 2018
- Employees
- 30
- Total funding
- $10M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 11 Jan 2022 | Series A | $10M | - |
Tech stack
Detected on graymatters-health.com, last scanned 24 Sept 2026. Run your own scan
- Observability
- Sentry
- CMS / Builders
- Wix
- CDN
- Cloudflare
- Email provider
- Microsoft 365
Frequently asked
How much funding has GrayMatters Health raised?
GrayMatters Health has raised a total of $10M in funding. The most recent round on record is Series A.
How many employees does GrayMatters Health have?
GrayMatters Health has approximately 30 people on record.